id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0125-0025,FDA,FDA-2013-N-0125,Guidance for Industry Alternative to Certain Prescription Device Labeling Requirements,Other,Guidance,2020-05-18T04:00:00Z,2020,5,2020-05-18T04:00:00Z,,2024-11-06T23:36:54Z,,1,0,0900006484635b8a